Terms: = Bone cancer AND MEN1, ENSG00000133895, 4221 AND Prognosis
3 results:
1. Epigenetic-based targeted therapies for well-differentiated pancreatic neuroendocrine tumors: recent advances and future perspectives.
Marini F; Giusti F; Brandi ML
Expert Rev Endocrinol Metab; 2021 Nov; 16(6):295-307. PubMed ID: 34554891
[TBL] [Abstract] [Full Text] [Related]
2. Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.
Du F; Yuan P; Wang JY; Ma F; Fan Y; Luo Y; Xu BH
Asian Pac J Cancer Prev; 2015; 16(3):903-7. PubMed ID: 25735380
[TBL] [Abstract] [Full Text] [Related]
3. Natural history of neuroendocrine enteropancreatic tumors.
Mignon M
Digestion; 2000; 62 Suppl 1():51-8. PubMed ID: 10940688
[TBL] [Abstract] [Full Text] [Related]
